Compared with the expression of MALAT1 in patients carrying different genotypes (Figure 3A), it can be indicated that the decreased MALAT1 level is associated with the decreased size of lung cancer lymph nodes (Figure 4B) and brain metastatic lung tumors (Figure 4C). Here, MALAT1 is linked to lung cancer.